Annuncio • Nov 16
Danimer Scientific, Inc. announced delayed 10-Q filing On 11/15/2024, Danimer Scientific, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Annuncio • Nov 05
Danimer Scientific Announces Intention to Complete a Reverse Stock Split to Regain Compliance with the Price Criteria of Section 802.01C of the NYSE Listed Company Manual Danimer Scientific, Inc. announced that, following approval by the Company's stockholders and its Board of Directors, the Company will effect a reverse stock split ('Reverse Stock Split') of Danimer's Class A common stock, par value $0.0001 per share ('Common Stock'), at a ratio of 1-for-40 (the 'Reverse Stock Split Ratio'), which ratio was determined by the Board of Directors from within a range of ratios authorized by the stockholders. The Reverse Stock Split is expected to become effective on November 12, 2024, after close of trading on the New York Stock Exchange ('NYSE'). The Common Stock is expected to begin trading on a split-adjusted basis when the markets open on November 13, 2024, under the existing trading symbol 'DNMR' and new CUSIP number (236272 407). The Company believes the Reverse Stock Split will increase the price per share of the Common Stock and thus enable it to regain compliance with the price criteria of Section 802.01C of the NYSE Listed Company Manual (the 'Minimum Share Price Rule'). Annuncio • Oct 28
Danimer Scientific Announces Second Circuit Court Affirms Dismissal of Class Action Lawsuit Danimer Scientific, Inc. announced that, on September 27, 2024, the United States Court of Appeals for the Second Circuit affirmed the 2023 Order of the United States District Court for the Eastern District of New York dismissing a previously disclosed putative class action complaint captioned In re Danimer Scientific, Inc. Securities Litigation. Subsequently, the plaintiffs in the three shareholder derivative cases that had been pending in state and federal courts in Delaware, which cases had been stayed pending the outcome of the Second Circuit case, dismissed their complaints. Annuncio • Aug 09
Danimer Scientific, Inc. Provides Financial Guidance for the Second Quarter of Fiscal 2025 Danimer Scientific, Inc. provides financial guidance for the second quarter of fiscal 2025. For the period, the company expects annualized PHA revenues to more than triple, based solely on demand from existing customer relationships and their indicated volumes, including the aforementioned 20-million-pound cutlery award. Annuncio • Aug 02
Danimer Scientific, Inc. to Report Q2, 2024 Results on Aug 08, 2024 Danimer Scientific, Inc. announced that they will report Q2, 2024 results After-Market on Aug 08, 2024 Annuncio • May 25
Danimer Scientific, Inc. Receives Non-Compliance Notice from NYSE Regulation On May 21, 2024, Danimer Scientific, Inc. (the Company") was notified by NYSE Regulation (NYSER") that the Company is not in compliance with the New York Stock Exchange's (NYSE") continued listing criteria under Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company's common stock was less than $1.00 over a consecutive 30 trading-day period as of May 20, 2024. The Company has notified the NYSE of its intent to cure the deficiency and return to compliance with the NYSE continued listing requirements. The Company will return to compliance if, during the six-month period following receipt of the NYSE notice, on the last trading-day of any calendar month, the Company's common stock has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month. Under NYSE rules, the Company's common stock will continue to be traded on the NYSE during this period, subject to the Company's compliance with other applicable continued listing requirements. The NYSER notification does not affect the Company's business operations, Securities and Exchange Commission reporting requirements or debt obligations. Annuncio • May 07
Danimer Scientific Reveals New Branding and New Applications Based on PHA During NPE 2024 Danimer Scientific, Inc. is unveiling new commercial applications and branding during NPE 2024, North America’s large plastics tradeshow, taking place this week in Orlando, FL. A more perfect polymer™ takes center stage at NPE 2024. Danimer’s signature PHA, Nodax®, represents a more perfect polymer revolution. PHAs (polyhydroxyalkanoates) are naturally made polymer chains, and at Danimer it harness microbes as tiny reactors to make its biopolymers, using canola oil as the renewable feedstock. The resulting PHA can be used to replace conventional plastics in uses from straws to lids, from coffee pods to flexible packaging, and from paper coatings to adhesives. With full PHA production capability in place, Danimer is poised for significant growth with commercial partners for several applications, including cutlery, flexible food packaging and paper packaging barrier coatings. Microbes, not Microplastics™ enables a new future for packaging items. Danimer is committed to offering solutions to address plastic pollution and the proliferation of microplastics. It is all about the microbes, both during origination and biodegradation. Microbes produce PHAs, and microbes biochemically recycle its PHAs, whether in industrial compost, home compost, soils, fresh water or the marine environment. Because a large class of microbes present in natural systems readily identify PHAs as a food source, there is no threat of residual microplastics. PHA grades are third party certified to fully biodegrade under various conditions, with the added benefit of no ecotoxicity concerns, PFAS or regulated metals. That makes Nodax a more perfect polymer™ for its planet. Annuncio • May 05
Danimer Scientific, Inc., Annual General Meeting, Jul 09, 2024 Danimer Scientific, Inc., Annual General Meeting, Jul 09, 2024. Annuncio • May 03
Danimer Scientific, Inc. to Report Q1, 2024 Results on May 07, 2024 Danimer Scientific, Inc. announced that they will report Q1, 2024 results After-Market on May 07, 2024 Reported Earnings • Mar 30
Full year 2023 earnings released: US$1.52 loss per share (vs US$1.78 loss in FY 2022) Full year 2023 results: US$1.52 loss per share (improved from US$1.78 loss in FY 2022). Revenue: US$46.7m (down 12% from FY 2022). Net loss: US$155.5m (loss narrowed 14% from FY 2022). Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Annuncio • Mar 26
Danimer Scientific, Inc. has completed a Follow-on Equity Offering in the amount of $14.999625 million. Danimer Scientific, Inc. has completed a Follow-on Equity Offering in the amount of $14.999625 million.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 11,250,000
Price\Range: $1
Discount Per Security: $0.07
Security Name: Warrants
Security Type: Equity Warrant
Securities Offered: 15,000,000
Security Name: Pre-Funded Warrants
Security Type: Equity Warrant
Securities Offered: 3,750,000
Price\Range: $0.9999
Discount Per Security: $0.06993
Transaction Features: Registered Direct Offering New Risk • Mar 24
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 12% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shares are highly illiquid. Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (US$92m net loss in 3 years). Shareholders have been diluted in the past year (12% increase in shares outstanding). Annuncio • Mar 21
Danimer Scientific, Inc. has filed a Follow-on Equity Offering in the amount of $34.95 million. Danimer Scientific, Inc. has filed a Follow-on Equity Offering in the amount of $34.95 million.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 15,000,000
Price\Range: $1
Security Name: Warrants
Security Type: Equity Warrant
Securities Offered: 15,000,000
Price\Range: $1.33
Transaction Features: Registered Direct Offering Annuncio • Jan 31
Danimer Scientific Receives Continued Listing Standard Notice from NYSE Danimer Scientific, Inc. announced that it received a notice from the New York Stock Exchange ('NYSE') on January 23, 2024, that the Company is not currently in compliance with the NYSE's continued listing standard requiring listed-company stock to maintain an average closing price of not less than $1.00 per share over a period of thirty (30) consecutive trading days. The Notice does not result in the immediate delisting of the Company's Common Stock from the NYSE. On January 26, 2024, the Company notified the NYSE that it intends to cure the stock price deficiency and return to compliance with the NYSE's minimum share price standard within the six-month period following receipt of the Notice. The Company's Common Stock will continue to be listed and trade on the NYSE during this period, subject to its compliance with other NYSE continued listing standards. The receipt of the Notice does not affect the Company's business, operations or reporting requirements with the Securities and Exchange Commission. The Company intends to consider all available options to cure its non-compliance with the NYSE minimum share price standard. The Company can regain compliance with the minimum share price requirement at any time during the six-month cure period if, on the last trading day of any calendar month during the cure period or on the last day of the cure period, the Company has (i) a closing share price of at least $1.00, and (ii) an average closing share price of at least $1.00 over the 30 trading-day periods ending on the last trading day of that month. Annuncio • Jan 19
Danimer Scientific, Inc. Announces New Directors Danimer Scientific, Inc. announced that Dr. David Moody and Mr. Richard Altice have been appointed as members of Danimer’s Board of Directors. Dr. Moody’s appointment is effective immediately, and Mr. Altice’s appointment is effective as of April 15, 2024. Dr. David J. Moody currently is a member of the Board of Directors of Jadex Inc., a US-based manufacturing and material science company utilizing innovation and technology to develop sustainable products that serve the medical, industrial and consumer markets. Dr. Moody previously served as Chief Executive Officer of Jadex from March 2021 through July 2023, and before that served in various roles of increasing responsibility at Milliken & Company culminating in the role of Executive Vice President and Division President, Chemicals. Dr. Moody has over thirty years’ experience managing chemical and polymer related businesses in various leadership roles and holds a Bachelor of Science in Chemistry from Wofford College and a Ph.D. in Chemistry from the Georgia Institute of Technology. Richard N. Altice most recently retired from NatureWorks, a developer and manufacturer of biopolymers (polylactic acid), where he served as President and CEO for five years. Prior to NatureWorks, Mr. Altice was the Senior Vice President and President of PolyOne’s Designed Structures and Solutions, a polymer and plastics converting and food packaging business, formerly known as Spartech. Additionally, Mr. Altice was Vice President of Hexion’s Global Specialty Epoxy resin business and was formerly the President of Solutia’s Technical Specialties division, responsible for the global rubber chemicals and specialty fluids businesses. Mr. Altice has over thirty years of sales, marketing, operational and management experience in the specialty chemicals and biopolymer industries and holds a Bachelor of Science in Chemical Engineering from the Missouri University of Science and Technology. With these changes, Danimer’s Board will be comprised of eleven directors. Annuncio • Nov 08
Danimer Scientific, Inc. to Report Q3, 2023 Results on Nov 14, 2023 Danimer Scientific, Inc. announced that they will report Q3, 2023 results After-Market on Nov 14, 2023 Annuncio • Oct 20
Danimer Scientific, BIOLO and Bolthouse Farms Announce Commercialization of Home Compostable Packaging for Fresh Produce with Meijer Stores Danimer Scientific, Inc. announced the commercialization of home compostable retail packaging for vegetables and fruit, which Danimer developed in partnership with biodegradable packaging and food service product manufacturer BIOLO and carrot producer Bolthouse Farms. Danimer’s signature PHA, Nodax®, was used to create the bags for one-pound Earthbound Farm Organic Mini Peeled Carrots, now available in Meijer’s regional network of 240 grocery stores and supercenters in six states across the Midwest. Danimer’s Nodax® is a biobased polyester made with oils derived from the seeds of plants such as canola. Unlike traditional plastic, which can take centuries to degrade, Danimer’s PHA-based products can degrade in a matter of months under certain conditions. The Earthbound Farm Organic Mini Peeled Carrots bags are certified as home compostable by TUV, a globally recognized leader in independent product testing, inspection and certification. This certification means that the bags have passed rigorous testing that requires them to disintegrate at least 90% within 26 weeks and biodegrade within 52 weeks under home compost conditions. Annuncio • Aug 01
Danimer Scientific, Inc. to Report Q2, 2023 Results on Aug 08, 2023 Danimer Scientific, Inc. announced that they will report Q2, 2023 results After-Market on Aug 08, 2023 Annuncio • May 04
Danimer Scientific, Inc. to Report Q1, 2023 Results on May 10, 2023 Danimer Scientific, Inc. announced that they will report Q1, 2023 results at 4:00 PM, US Eastern Standard Time on May 10, 2023 Annuncio • Nov 09
Danimer Scientific, Inc. Reports Impairment Charges for the Third Quarter Ended September 30, 2022 Danimer Scientific, Inc. reported impairment charges for the third quarter ended September 30, 2022. For the quarter, the company reported impairment of goodwill of $62,663,000. Annuncio • Oct 26
Danimer Scientific, Inc. to Report Q3, 2022 Results on Nov 08, 2022 Danimer Scientific, Inc. announced that they will report Q3, 2022 results at 4:00 PM, US Eastern Standard Time on Nov 08, 2022 Annuncio • Sep 21
Danimer Scientific Appoints Stephen Martin as Chief Legal Officer and Corporate Secretary Danimer Scientific, Inc. announced it has appointed Stephen Martin as Chief Legal Officer and Corporate Secretary. In this role, Martin will manage a wide range of legal matters across the company as Danimer continues to expand its manufacturing capacity to meet demand in the fast-growing bioplastics market.Martin joins Danimer from Kaman Distribution Group, a leading national distributor of highly engineered products and services, where he had served as General Counsel and Corporate Secretary from 2020 until that company’s successful sale earlier this year. Before that, he was General Counsel and Corporate Secretary for Accuride Corporation, a vehicle components manufacturer, starting in 2008. Martin served as an officer in the Air Force from 1992 to 1998, managing the procurement of avionics systems for the Atlas Launch Vehicle system and serving on a satellite command and control squadron responsible for operating a constellation of satellites. He is a distinguished graduate of Squadron Officer School. Martin received his Juris Doctor from Duke University School of Law in 2001, graduating cum laude. He received his master’s from the University of Southern California and his bachelor’s degree from the University of Miami, both in electrical engineering. Recent Insider Transactions • Aug 24
Director recently sold €869k worth of stock On the 19th of August, Stuart Pratt sold around 175k shares on-market at roughly €4.96 per share. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Annuncio • Aug 17
Danimer Scientific, Inc. Elects Board Members Danimer Scientific, Inc. held its Annual Meeting of Stockholders on August 11, 2022, elected Cynthia Cohen and Allison M. Leopold Tilley to its Board of Directors. 
